Legal Advantage Investments, Inc. Illumina, Inc. Transaction History

Legal Advantage Investments, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	SELL	$92.79 - $142.53 $9,279 - $14,253	-100 Reduced 2.27%	4,305 $599,000
Q3 2023 Oct 25, 2023	SELL	$128.91 - $192.44 $3,222 - $4,811	-25 Reduced 0.56%	4,405 $604,000
Q2 2023 Jul 31, 2023	SELL	$183.43 - $232.67 $91,715 - $116,335	-500 Reduced 10.14%	4,430 $830,000
Q1 2023 Apr 24, 2023	BUY	$193.75 - $232.55 $736,250 - $883,690	3,800 Added 336.28%	4,930 $1.15 Million
Q4 2022 Feb 01, 2023	BUY	$187.24 - $242.74 $211,581 - $274,296	1,130 New	1,130 $228,000
Q2 2022 Jul 26, 2022	SELL	$181.58 - $368.0 $820,741 - $1.66 Million	-4,520 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$347.28 - $421.83 $27,782 - $33,746	-80 Reduced 1.74%	4,520 $1.72 Million
Q3 2021 Oct 25, 2021	SELL	$405.61 - $524.84 $10,140 - $13,121	-25 Reduced 0.54%	4,600 $1.87 Million
Q1 2021 May 06, 2021	BUY	$361.28 - $504.76 $14,451 - $20,190	40 Added 0.87%	4,625 $1.78 Million
Q4 2020 Jan 28, 2021	BUY	$292.7 - $370.96 $1.34 Million - $1.7 Million	4,585 New	4,585 $1.7 Million

852

138M

1.41M

1.66M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.2B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Legal Advantage Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Legal Advantage Investments, Inc. with notifications on news.